BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27573894)

  • 1. MicroRNAs and Inflammation in Colorectal Cancer.
    Josse C; Bours V
    Adv Exp Med Biol; 2016; 937():53-69. PubMed ID: 27573894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.
    Yang Y; Du Y; Liu X; Cho WC
    Adv Exp Med Biol; 2016; 937():19-51. PubMed ID: 27573893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.
    Fanale D; Barraco N; Listì A; Bazan V; Russo A
    Adv Exp Med Biol; 2016; 937():93-108. PubMed ID: 27573896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of MicroRNAs in Inflammation-Associated Colorectal Cancer: A Mechanistic Approach.
    Muthusami S; Ramachandran I; Krishnamoorthy S; Sambandam Y; Ramalingam S; Queimado L; Chaudhuri G; Ramachandran IK
    Endocr Metab Immune Disord Drug Targets; 2021; 21(1):67-76. PubMed ID: 32940190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of microRNAs in Development of Colitis-Associated Colorectal Cancer.
    Bocchetti M; Ferraro MG; Ricciardiello F; Ottaiano A; Luce A; Cossu AM; Scrima M; Leung WY; Abate M; Stiuso P; Caraglia M; Zappavigna S; Yau TO
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics.
    Yamamoto H; Mori M
    Adv Exp Med Biol; 2016; 937():239-47. PubMed ID: 27573904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer.
    Zhao D; Sui Y; Zheng X
    Oncol Rep; 2016 Feb; 35(2):1075-82. PubMed ID: 26718987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathological role of microRNAs and inflammation in colon carcinogenesis.
    Zhang L; Fan XM
    Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):174-9. PubMed ID: 25154001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs, intestinal inflammatory and tumor.
    Feng Y; Zhang Y; Zhou D; Chen G; Li N
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2051-2058. PubMed ID: 31213403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
    Azer SA
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathways underlying IBD-associated colorectal neoplasia: therapeutic implications.
    Goel GA; Kandiel A; Achkar JP; Lashner B
    Am J Gastroenterol; 2011 Apr; 106(4):719-30. PubMed ID: 21386829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.
    Yashiro M
    Dig Dis Sci; 2015 Aug; 60(8):2251-63. PubMed ID: 25840920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Inflammation to Cancer in Inflammatory Bowel Disease: Molecular Perspectives.
    Romano M; DE Francesco F; Zarantonello L; Ruffolo C; Ferraro GA; Zanus G; Giordano A; Bassi N; Cillo U
    Anticancer Res; 2016 Apr; 36(4):1447-60. PubMed ID: 27069120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HNE and cholesterol oxidation products in colorectal inflammation and carcinogenesis.
    Rossin D; Calfapietra S; Sottero B; Poli G; Biasi F
    Free Radic Biol Med; 2017 Oct; 111():186-195. PubMed ID: 28089726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenetic and clinical relevance of microRNAs in colorectal cancer.
    Valeri N; Croce CM; Fabbri M
    Cancer Genomics Proteomics; 2009; 6(4):195-204. PubMed ID: 19656996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.
    Li X; Nie J; Mei Q; Han WD
    World J Gastroenterol; 2016 Jun; 22(23):5317-31. PubMed ID: 27340348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.
    Fanale D; Castiglia M; Bazan V; Russo A
    Adv Exp Med Biol; 2016; 937():207-28. PubMed ID: 27573902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating analysis reveals microRNA-mediated pathway crosstalk among Crohn's disease, ulcerative colitis and colorectal cancer.
    Bai J; Li Y; Shao T; Zhao Z; Wang Y; Wu A; Chen H; Li S; Jiang C; Xu J; Li X
    Mol Biosyst; 2014 Jul; 10(9):2317-28. PubMed ID: 24949825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation and colorectal cancer.
    Kraus S; Arber N
    Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-143 inhibits colorectal cancer cell proliferation by targeting MMP7.
    Yu B; Liu X; Chang H
    Minerva Med; 2017 Feb; 108(1):13-19. PubMed ID: 27827523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.